The status and controversy of minimally invasive treatment of pancreatic cancer
10.3760/cma.j.cn113884-20200421-00221
- VernacularTitle:胰腺癌微创治疗的现状及争议
- Author:
Taiping ZHANG
1
;
Yueze LIU
;
Jiangdong QIU
Author Information
1. 中国医学科学院北京协和医学院 北京协和医院基本外科，北京 100730
- From:
Chinese Journal of Hepatobiliary Surgery
2020;26(8):564-568
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer is extremely malignant and has poor prognosis. Surgery is the only way for the therapy. In recent years, minimally invasive surgery has been developed rapidly in pancreatic surgery. However, pancreatic cancer is often accompanied with vascular aggression and inflammation, which greatly increasing the difficulty of minimally invasive surgery procedure. Its feasibility, safety and radical tumor cure are still controversial. In this article, combined with the existing guidelines and the latest clinical researches, we compared the application of minimally invasive and open surgery in pancreatic cancer and summarized the development status and controversy of minimally invasive treatment of pancreatic cancer. Surgeons should strictly grasp the minimally invasive surgical adaptation certificate, and further carry out clinical research on minimally invasive treatment of pancreatic cancer, so as to standardize and enhance the development of minimally invasive pancreatic surgery in China.
